POMDOCTOR LIMITED
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving POMDOCTOR LIMITED now
Current reporting with the operating signal separated from the noise.
POMDOCTOR LIMITED Highlights Four-Tier Diversified Revenue Structure
Investors are testing whether POMDOCTOR LIMITED’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.POMDOCTOR LIMITED Announces Strategic Upgrade Toward Infrastructure for Predictive Healthcare Data and Services
The story matters when it changes POMDOCTOR LIMITED’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.POMDOCTOR LIMITED Announces ADS Ratio Change to Be Effective on June 22, 2026
The story matters when it changes POMDOCTOR LIMITED’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.POMDOCTOR LIMITED Announces Fiscal Year 2025 Financial Results
The story matters when it changes POMDOCTOR LIMITED’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.POMDOCTOR LIMITED Announces Strategic Upgrade, Focusing on "AI + Medical-Grade Smart Wearables" to Build a New Ecosystem for Full-Cycle Chronic Disease Management
The development tests whether POMDOCTOR LIMITED can turn product investment into adoption, revenue and durable advantage.
Watch next: confirmation in a company filing, official release or regulator record.POMDOCTOR LIMITED Drive Internet Hospital Growth Through Strengthened Strategic Partnerships With Pharmaceutical Companies
The story matters when it changes POMDOCTOR LIMITED’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.POMDOCTOR LIMITED Announces Full Exercise and Closing of Underwriter's Over-Allotment Option
The story matters when it changes POMDOCTOR LIMITED’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.POMDOCTOR LIMITED Announces Pricing of Initial Public Offering
The story matters when it changes POMDOCTOR LIMITED’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Latest POM filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
POMDOCTOR LIMITED, quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
No verified period-specific item in the current feed.
SEARCH Q1 COVERAGE →Second quarter
No verified period-specific item in the current feed.
SEARCH Q2 COVERAGE →Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →Fourth quarter / full year
No verified period-specific item in the current feed.
SEARCH Q4 COVERAGE →